financetom
Business
financetom
/
Business
/
MeridianLink Swings to Q4 Non-GAAP Earnings, Revenue Rises; 2025 Revenue Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MeridianLink Swings to Q4 Non-GAAP Earnings, Revenue Rises; 2025 Revenue Outlook Issued
Mar 6, 2025 1:37 PM

04:26 PM EST, 03/06/2025 (MT Newswires) -- MeridianLink ( MLNK ) reported Q4 non-GAAP earnings late Thursday of $0.08 per diluted share, compared with a loss of $0.29 a year earlier.

Analysts polled by FactSet expected EPS of $0.08.

Revenue for the quarter ended Dec. 31 was $79.4 million, up from $74.6 million a year earlier.

Analysts surveyed by FactSet expected $78.2 million.

MeridianLink ( MLNK ) said it expects full-year 2025 revenue of $326 million to $334 million. Analysts polled by FactSet expect $332.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nexstar Media Q3 Net Income, Revenue Fall
Nexstar Media Q3 Net Income, Revenue Fall
Nov 6, 2025
07:46 AM EST, 11/06/2025 (MT Newswires) -- Nexstar Media Group ( NXST ) reported Q3 net income Thursday of $2.14 per diluted share, down from $5.27 a year earlier. Analysts polled by FactSet expected $2.36. Net revenue for the quarter ended Sept. 30 was $1.20 billion, compared with $1.37 billion a year earlier. Analysts surveyed by FactSet expected $1.20 billion....
NRG Energy Q3 Adjusted Earnings, Revenue Rise; 2025 Adjusted Earnings Guidance Raised
NRG Energy Q3 Adjusted Earnings, Revenue Rise; 2025 Adjusted Earnings Guidance Raised
Nov 6, 2025
07:48 AM EST, 11/06/2025 (MT Newswires) -- NRG Energy ( NRG ) reported Q3 adjusted earnings Thursday of $2.78 per diluted share, up from $2.10 a year earlier. Analysts surveyed by FactSet expected $1.99. Revenue for the quarter ended Sept. 30 was $7.64 billion, up from $7.22 billion a year earlier. Analysts polled by FactSet expected $7.46 billion. The company...
Lilly moves obesity drug to late-stage trials after it shows promise
Lilly moves obesity drug to late-stage trials after it shows promise
Nov 6, 2025
* Drug shows weight reduction from 9.5% to up to 20.1% * Lilly plans to start late-stage trials by year end * Eloralintide mimics the pancreatic hormone amylin (Recasts paragraph 1, adds share movement in paragraphs 2 and 5, background in 13) Nov 6 (Reuters) - Eli Lilly ( LLY ) said on Thursday it will start late-stage trials of...
Cannabis company TerrAscend Q3 revenue misses estimates
Cannabis company TerrAscend Q3 revenue misses estimates
Nov 6, 2025
Overview * TerrAscend ( TSNDF ) Q3 revenue of $65.1 mln missed analyst expectations * Company reports Q3 net loss from continuing operations of $9.9 mln * Completed $79 mln refinancing and had said it plans to exit Michigan market by year-end Outlook * Company evaluating strategic M&A opportunities with a disciplined approach * TerrAscend ( TSNDF ) aims to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved